197 related articles for article (PubMed ID: 36728978)
1. Assessments of CYP‑inhibition‑based drug-drug interaction between vonoprazan and poziotinib
Zhou S; Zhao FL; Wang SH; Wang YR; Hong Y; Zhou Q; Geng PW; Luo QF; Cai JP; Dai DP
Pharm Biol; 2023 Dec; 61(1):356-361. PubMed ID: 36728978
[TBL] [Abstract][Full Text] [Related]
2. Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo.
Hong Y; Dai DP; Cai JP; Wang SH; Wang YR; Zhao FL; Zhou S; Zhou Q; Geng PW; Zhou YF; Xu X; Shi JH; Luo QF
Drug Des Devel Ther; 2022; 16():1779-1789. PubMed ID: 35707687
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of Schisandrin on the pharmacokinetics of poziotinib in vivo and in vitro by UPLC-MS/MS.
Wang S; Xia M; Wang Y; Lu Z; Geng P; Dai D; Zhou Y; Wu Q
Thorac Cancer; 2023 May; 14(14):1276-1285. PubMed ID: 36973912
[TBL] [Abstract][Full Text] [Related]
4. Effects of dacomitinib on the pharmacokinetics of poziotinib
Ji W; Shen J; Wang B; Chen F; Meng D; Wang S; Dai D; Zhou Y; Wang C; Zhou Q
Pharm Biol; 2021 Dec; 59(1):457-464. PubMed ID: 33899675
[TBL] [Abstract][Full Text] [Related]
5. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes
Wang J; Chen F; Jiang H; Xu J; Meng D; Geng P; Dai D; Hu J; Zhou Y; Zhou Q; Wang S
Front Pharmacol; 2020; 11():593518. PubMed ID: 33746741
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine.
Chen F; Jiang H; Xu J; Wang S; Meng D; Geng P; Dai D; Zhou Q; Zhou Y
Drug Des Devel Ther; 2020; 14():4815-4824. PubMed ID: 33204067
[TBL] [Abstract][Full Text] [Related]
8. Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats.
Shen J; Wang B; Wang S; Chen F; Meng D; Jiang H; Zhou Y; Geng P; Zhou Q; Liu B
Drug Des Devel Ther; 2020; 14():2199-2206. PubMed ID: 32581516
[TBL] [Abstract][Full Text] [Related]
9. Effects of bergapten on the pharmacokinetics of macitentan in rats both
Xu J; Zhou Q; Hou P; Wang Y; Geng P; Lu Z; Zhou Y; Dai D; Wang S
Front Pharmacol; 2023; 14():1204649. PubMed ID: 37492094
[TBL] [Abstract][Full Text] [Related]
10. The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
Zhou Q; Ye F; Ye Z; Gao N; Kong Q; Hu X; Qian J; Wu B
PeerJ; 2023; 11():e16601. PubMed ID: 38089912
[TBL] [Abstract][Full Text] [Related]
11. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
[TBL] [Abstract][Full Text] [Related]
12. Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats.
Bao SS; Tang PF; Gao NY; Xiao ZX; Qian JC; Zheng L; Hu GX; Xu HH
PeerJ; 2023; 11():e16051. PubMed ID: 37719112
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS.
Lin QM; Pang NH; Li YH; Huang HL; Zhang XD; Hu GX; Wang ZS
Chem Biol Interact; 2019 Sep; 310():108744. PubMed ID: 31299239
[TBL] [Abstract][Full Text] [Related]
14. The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone.
Li Q; Wang J; Wang ZL; Shen Y; Zhou Q; Liu YN; Hu GX; Cai JP; Xu RA
Biomed Pharmacother; 2023 Dec; 168():115833. PubMed ID: 37935069
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel.
Nishihara M; Yamasaki H; Czerniak R; Jenkins H
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):217-227. PubMed ID: 30361928
[TBL] [Abstract][Full Text] [Related]
16. The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
Hu Y; Xie S; Xia H; Chen J; Yang Y; Zhan R
Toxicol Appl Pharmacol; 2024 Jan; 482():116797. PubMed ID: 38160892
[TBL] [Abstract][Full Text] [Related]
17. The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline.
Hu X; Ni J; Gao N; Ye Z; Hu G; Cai J; Qian J
Chem Biol Interact; 2022 Oct; 366():110123. PubMed ID: 36007633
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS.
Xia M; Song X; Lu Z; Wang Y; Zhou Q; Geng P; Wang S; Zhou Y; Wu Q; Han A
Thorac Cancer; 2023 Nov; 14(33):3331-3341. PubMed ID: 37771131
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of napabucasin on arbidol metabolism and its mechanism research.
Nie J; Xia H; Liu YN; Yu Y; Xu RA
Front Pharmacol; 2023; 14():1292354. PubMed ID: 38094891
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan
Wang Y; Wang C; Wang S; Zhou Q; Dai D; Shi J; Xu X; Luo Q
Front Pharmacol; 2020; 11():53. PubMed ID: 32116727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
